Korro Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Korro Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Korro Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Korro Bio Inc. is KRRO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Korro Bio Inc. has its primary listing on NASDAQ. You can trade Korro Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Korro Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Korro Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Korro Bio Inc..